Benign Hepatic Tumors: From Incidental Imaging Finding to Clinical Management
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Benign hepatic tumors (BHTs) are commonly detected as incidental finding mainly due to the frequent utilization of imaging modalities, including ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI). Rigorous clinical evaluation, with a particular focus on chronic liver disease (CLD) or risk factors for CLD, medication history, physical examination for signs of CLD, blood tests, and a review of past liver radiology constitute the initial steps in the evaluation of a new liver lesion. Further, contrast-enhanced imaging using US, CT and MRI, can be used depending on the clinical scenario and their availability. The contrast-enhanced MRI provides detailed tissue assessment while avoiding exposure to radiations, although it is scarcely available and expensive. While the liver tissue-specific protocols ensure precise diagnosis, a biopsy is recommended in selected or doubtful cases. Further, most BHTs, such as hemangiomas, are harmless and do not require special management or followup, the hepatic adenomas and large or atypical cases of focal nodular hyperplasia are clinically relevant and require management/follow-up. In such cases, it is favorable to have a multidisciplinary team approach, which includes hepatologist, radiologist, hepatobiliary surgeon, and pathologist. This review aims to elaborate the current understanding of BHTs, and provide a practical guidance for primary care and practitioners of family and internal medicine for the disease evaluation and management.
Abstract
Benign hepatic tumors (BHTs) are commonly detected as incidental finding mainly due to the frequent utilization of imaging modalities, including ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI). Rigorous clinical evaluation, with a particular focus on chronic liver disease (CLD) or risk factors for CLD, medication history, physical examination for signs of CLD, blood tests, and a review of past liver radiology constitute the initial steps in the evaluation of a new liver lesion. Further, contrast-enhanced imaging using US, CT and MRI, can be used depending on the clinical scenario and their availability. The contrast-enhanced MRI provides detailed tissue assessment while avoiding exposure to radiations, although it is scarcely available and expensive. While the liver tissue-specific protocols ensure precise diagnosis, a biopsy is recommended in selected or doubtful cases. Further, most BHTs, such as hemangiomas, are harmless and do not require special management or followup, the hepatic adenomas and large or atypical cases of focal nodular hyperplasia are clinically relevant and require management/follow-up. In such cases, it is favorable to have a multidisciplinary team approach, which includes hepatologist, radiologist, hepatobiliary surgeon, and pathologist. This review aims to elaborate the current understanding of BHTs, and provide a practical guidance for primary care and practitioners of family and internal medicine for the disease evaluation and management.
참고문헌 (37)
- Smith-Bindman R, "Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated health care systems, 1996-2010", JAMA, 307, pp.2400~2409 (2012)
- Marin D, "Imaging approach for evaluation of focal liver lesions", Clin Gastroenterol Hepatol, 7, pp.624~634 (2009)
- Rungsinaporn K, "Frequency of abnormalities detected by upper abdominal ultrasound", J Med Assoc Thai, 91, pp.1072~1075 (2008)
- Bahirwani R, "Review article: the evaluation of solitary liver masses", Aliment Pharmacol Ther, 28, pp.953~965 (2008)
- Horta G, "Benign focal liver lesions detected by computed tomography: review of 1,184examinations", Rev Med Chil, 143, pp.197~202 (2015)
- Mergo PJ, "Benign lesions of the liver", Radiol Clin North Am, 36, pp.319~331 (1998)
- Shaked O, "Biologic and clinical features of benign solid and cystic lesions of the liver", Clin Gastroenterol Hepatol, 9, pp.547~562 (2011)
- Gemer O, "Oral contraceptives and liver hemangioma: a case-control study", Acta Obstet Gynecol Scand, 83, pp.1199~1201 (2004)
- Kasabach HH, "Capillary hemangioma with extensive purpura: report of a case", Am J Dis Child, 59, pp.1063~1070 (1940)
- Quaia E, "Characterization of liver hemangiomas with pulse inversion harmonic imaging", Eur Radiol, 12, pp.537~544 (2002)
- European Association for the Study of the Liver, "EASL clinical practice guidelines on the management of benign liver tumours", J Hepatol, 65, pp.386~398 (2016)
- Marrero JA, "ACG clinical guideline: the diagnosis and management of focal liver lesions", Am J Gastroenterol, 109, pp.1328~1348 (2014)
- Toro A, "What is changing in indications and treatment of hepatic hemangiomas. A review", Ann Hepatol, 13, pp.327~339 (2014)
- Brancatelli G, "Focal nodular hyperplasia: CT findings with emphasis on multiphasic helical CT in 78 patients", Radiology, 219, pp.61~68 (2001)
- Sato Y, "Hepatic stellate cells are activated around central scars of focal nodular hyperplasia of the liver: a potential mechanism of central scar formation", Hum Pathol, 40, pp.181~188 (2009)
- Rifai K, "No evidence of substantial growth progression or complications of large focal nodular hyperplasia during pregnancy", Scand J Gastroenterol, 48, pp.88~92 (2013)
- Perrakis A, "Management of the focal nodular hyperplasia of the liver: evaluation of the surgical treatment comparing with observation only", Am J Surg, 204, pp.689~696 (2012)
- Suh CH, "The diagnostic value of Gd-EOB-DTPA-MRI for the diagnosis of focal nodular hyperplasia: a systematic review and meta-analysis", Eur Radiol, 25, pp.950~960 (2015)
- McInnes MD, "Focal nodular hyperplasia and hepatocellular adenoma: accuracy of gadoxetic acid-enhanced MR imaging: a systematic review", Radiology, 277, pp.413~423 (2015)
- Maillette de Buy Wenniger L, "Focal nodular hyperplasia and hepatic adenoma: epidemiology and pathology", Dig Surg, 27, pp.24~31 (2010)
- Lin H, "Systematic review of hepatocellular adenoma in China and other regions", J Gastroenterol Hepatol, 26, pp.28~35 (2011)
- Rosenberg L, "The risk of liver neoplasia in relation to combined oral contraceptive use", Contraception, 43, pp.643~652 (1991)
- Rooks JB, "Epidemiology of hepatocellular adenoma: the role of oral contraceptive use", JAMA, 242, pp.644~648 (1979)
- Lin H, "Systematic review of hepatocellular adenoma in China and other regions", J Gastroenterol Hepatol, 26, pp.28~35 (2011)
- Bioulac-Sage P, "Hepatocellular adenoma:classification, variants and clinical relevance", Semin Diagn Pathol, 34, pp.112~125 (2017)
- Labrune P, "Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43patients and review of the literature", J Pediatr Gastroenterol Nutr, 24, pp.276~279 (1997)
- Resnick MB, "Hepatic adenoma in the pediatric age group. Clinicopathological observations and assessment of cell proliferative activity", Am J Surg Pathol, 19, pp.1181~1190 (1995)
- Bunchorntavakul C, "Clinical features and natural history of hepatocellular adenomas: the impact of obesity", Aliment Pharmacol Ther, 34, pp.664~674 (2011)
- Bioulac-Sage P, "Hepatocellular adenoma subtypes: the impact of overweight and obesity", Liver Int, 32, pp.1217~1221 (2012)
- Bieze M, "Risk factors for bleeding in hepatocellular adenoma", Br J Surg, 101, pp.847~855 (2014)
- Foster JH, "The malignant transformation of liver cell adenomas", Arch Surg, 129, pp.712~717 (1994)
- Farges O, "Changing trends in malignant transformation of hepatocellular adenoma", Gut, 60, pp.85~89 (2011)
- Bioulac-Sage P, "Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience", Hepatology, 50, pp.481~489 (2009)
- Thomeer MG, "Hepatocellular adenoma: when and how to treat?: update of current evidence", Therap Adv Gastroenterol, 9, pp.898~912 (2016)
- Bossen L, "Men with biopsyconfirmed hepatocellular adenoma have a high risk of progression to hepatocellular carcinoma: a nationwide population-based study", Liver Int, 37, pp.1042~1046 (2017)
- Van Rosmalen BV, "Systematic review of transarterial embolization for hepatocellular adenomas", Br J Surg, 104, pp.823~835 (2017)
- Noels JE, "Management of hepatocellular adenoma during pregnancy", J Hepatol, 54, pp.553~558 (2011)